We are live on ! Find out more
SFM

Soros Fund Management Portfolio holdings

AUM $9.12B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$13.3B
AUM Growth
+$3.15B
Cap. Flow
+$1.42B
Cap. Flow %
10.7%
Top 10 Hldgs %
37.99%
Holding
496
New
189
Increased
62
Reduced
64
Closed
132

Top Buys

Rank Stock Value
1
YPF icon
YPF
YPF
+$259M
2
CNX icon
CNX Resources
CNX
+$224M
3
META icon
Meta Platforms (Facebook)
META
+$110M
4
AAPL icon
Apple
AAPL
+$103M
5
AIG icon
American International
AIG
+$93.1M

Top Sells

Rank Stock Value
1
FDX icon
FedEx
FDX
+$163M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$155M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$129M
4
B
Barrick Mining
B
+$109M
5
MNST icon
Monster Beverage
MNST
+$102M

Sector Composition

Rank Sector Weight
1 Energy 14.44%
2 Technology 10.36%
3 Healthcare 8.13%
4 Communication Services 6.46%
5 Consumer Discretionary 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRTX
326
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$71K ﹤0.01%
+18
New +$67.7K
WSTL
327
DELISTED
Westell Technologies Inc
WSTL
$70K ﹤0.01%
+7,150
New +$83.3K
IFT
328
DELISTED
IMPERIAL HLDGS INC COM STK (FL)
IFT
$70K ﹤0.01%
+10,200
New +$66.1K
BIOL
329
DELISTED
Biolase, Inc.
BIOL
$68K ﹤0.01%
+2
New +$51.1K
ANAD
330
DELISTED
ANADIGICS INC
ANAD
$67K ﹤0.01%
+82,700
New +$103K
OHAI
331
DELISTED
OHA Investment Corporation
OHAI
$65K ﹤0.01%
+10,400
New +$67.6K
GMO
332
DELISTED
General Moly, Inc.
GMO
$63K ﹤0.01%
+54,400
New +$56.8K
KODK.WS
333
DELISTED
Eastman Kodak Company
KODK.WS
$63K ﹤0.01%
6,681
– –
GYRE icon
334
Gyre Therapeutics
GYRE
$648M
$62K ﹤0.01%
+18
New +$58.7K
KODK.WS.A
335
DELISTED
Eastman Kodak Company
KODK.WS.A
$61K ﹤0.01%
6,681
– –
TRAW icon
336
Traws Pharma
TRAW
$6.72M
– –
0
– –
ATEC icon
337
Alphatec Holdings
ATEC
$1.49B
$58K ﹤0.01%
+2,985
New +$50.1K
LINC icon
338
Lincoln Educational Services
LINC
$1.33B
$57K ﹤0.01%
+12,700
New +$50.3K
NPTN
339
DELISTED
NEOPHOTONICS CORP
NPTN
$57K ﹤0.01%
+13,800
New +$73K
PZG icon
340
Paramount Gold Nevada
PZG
$99.5M
$56K ﹤0.01%
+58,300
New +$60.3K
MITK icon
341
Mitek Systems
MITK
$771M
$54K ﹤0.01%
+16,358
New +$55.7K
ONCT
342
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$54K ﹤0.01%
+28
New +$55.4K
RSYS
343
DELISTED
Radisys Corp
RSYS
$53K ﹤0.01%
+15,296
New +$49.4K
INTX
344
DELISTED
Intersections, Inc.
INTX
$52K ﹤0.01%
+10,500
New +$52.4K
ENZN
345
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$52K ﹤0.01%
+50,123
New +$47.8K
RCPI
346
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$52K ﹤0.01%
+3,512
New +$60.9K
HTCH
347
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$52K ﹤0.01%
+20,986
New +$49.6K
FSGI
348
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
$51K ﹤0.01%
+23,400
New +$46.8K
FBIO icon
349
Fortress Biotech
FBIO
$109M
$50K ﹤0.01%
+1,952
New +$51.5K
IMN
350
DELISTED
Imation
IMN
$46K ﹤0.01%
+13,500
New +$55.7K
12 13
14
15 16

Similar funds

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
RWP
RWA Wealth Partners Newton, Massachusetts $9.14B AUM 16.57% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $9.18B AUM 25.04% 1-Year Est. Return
VAS
Vestmark Advisory Solutions Wakefield, Massachusetts $9.02B AUM 20.58% 1-Year Est. Return
A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $8.99B AUM 44.68% 1-Year Est. Return

Soros Fund Management's Q2 2014 Portfolio in Review

As of Q2 2014, Soros Fund Management held 496 positions worth $13.3B, up 31% from $10.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Soros Fund Management deployed $1.42B of net new capital in Q2 2014, opening 189 new positions and adding to 62 existing holdings. Its largest new stake was CNX Resources: 6,105,940 shares worth $234M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $155M trimmed.

  • Soros Fund Management's largest Q2 2014 buy was CNX Resources: 6,105,940 shares worth $234M.
  • Soros Fund Management added most to YPF in Q2 2014, an estimated $259M increase.
  • Soros Fund Management's biggest Q2 2014 reduction was Teva Pharmaceuticals, cutting an estimated $155M.
  • Soros Fund Management fully exited FedEx in Q2 2014, selling an estimated $163M.
  • Soros Fund Management's ten largest holdings make up 38% of its $13.3B portfolio in Q2 2014.
  • Soros Fund Management opened 189 new positions and closed 132 in Q2 2014.
  • Soros Fund Management's portfolio value rose 31% quarter-over-quarter to $13.3B.

Based on Soros Fund Management's 13F filing for Q2 2014, filed 14 Aug 2014.